Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy: a systematic review

QR Code

Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy: a systematic review

This systematic review sought to summarise data on the efficacy of vonoprazan, a novel potassium-competitive acid blocker, as compared with a proton pump inhibitor (PPI)-based regimen for first-line treatment of Helicobacter pylori eradication. A systematic literature search of MEDLINE, EMBASE, an...

Full description

Bibliographic Details
Main Authors:	Nur Azlina Mohd Fahami, Nur Aishah Che Roos
Format:	Article
Language:	English
Published:	Penerbit Universiti Kebangsaan Malaysia 2020
Online Access:	http://journalarticle.ukm.my/15472/ http://journalarticle.ukm.my/15472/1/15.pdf

Similar Items

In vitro study of anti-Helicobacter pylori activity of honey: a systematic review
by: Adam Quraisiah,, et al.
Published: (2020)

Corrigendum: Food Allergy and Helicobacter pylori Infection: A Systematic Review
by: Zheng, Feei Ma, et al.
Published: (2016)

Unravelling the metabolic and immunological impacts of helicobacter pylori eradication in healthy adult/youth through omics / Theresa Yap Wan Chen
by: Theresa Yap, Wan Chen
Published: (2017)

Production Of Recombinant Urease For Screening Of Helicobacter Pylori Infection
by: Mohamad, Che Wan Sharifah Robiah
Published: (2014)

The role of LuxS in metabolism and signalling in Helicobacter pylori
by: Shen, Feifei
Published: (2010)

The role of Interleukin-10 in Helicobacter pylori infection
by: Zakaria, Zuraihan
Published: (2010)

Immunoregulatory properties of Helicobacter pylori derived molecules
by: Ogbodo, Ekene N.
Published: (2021)

Regulatory B and T cells in Helicobacter pylori infection
by: Reddiar, Dona
Published: (2018)

The prevalence of helicobacter pylori in referral population of Turkey
by: Usarov, Komiljon, et al.
Published: (2021)

Association of Helicobacter pylori with colorectal cancer development.
by: Fouad Alsamaka, Fadi, et al.
Published: (2010)

Epidemiology of proton pump inhibitors therapy: an examination of the use and safety in general practice
by: Othman, Fatmah
Published: (2017)

Genetic determinants of Helicobacter pylori vacuolating cytotoxin activity
by: Letley, Darren Peter
Published: (2011)

Helicobacter pylori biomimics for gastric-targeted drug delivery
by: Hage, N.
Published: (2016)

Identification and surveillance of antibiotic resistance in Helicobacter pylori in the UK
by: Garvey, Elizabeth
Published: (2025)

Determinants of Helicobacter pylori density in the human stomach and implications in disease
by: Patel, Sapna Rohitbhai
Published: (2011)

The pathogenesis of Helicobacter pylori associated diseases in Kurdistan region, Iraq
by: Hussein, Nawfal Rasheed
Published: (2009)

Helicobacter pylori: cellular immunity and protection from Multiple Sclerosis
by: Jenkins, Harry H.
Published: (2022)

Expressions of P-glycoprotein in treatment: Resistant Helicobacter pylori patients
by: Omar, Marhanis, et al.
Published: (2014)

Gastric-targeted drug delivery by learning from Helicobacter pylori
by: Paraskevopoulou, Vasiliki
Published: (2019)

Forecasting of infection prevalence of helicobacter pylori using regression analysis
by: Usarov, Komiljon, et al.
Published: (2022)

Ethnicity association of Helicobacter pylori virulence genotype and metronidazole susceptibility
by: Hanafiah, Alfizah, et al.
Published: (2013)

The prevalence of co-administration of clopidogrel and proton pump inhibitors
by: Shrestha, Kajal, et al.
Published: (2011)

Proteome comparison of helicobacter pylori isolates associated with four disease groups
by: McWilliams, Tracy
Published: (2006)

Clinical and histopathological relevance of helicobacter pylori BabA2 genotype
by: Elhashima, Tariq, et al.
Published: (2016)

Determinants of vacuolating cytotoxin production and its impact on Helicobacter pylori pathogenesis
by: Masters, Charlotte Grace
Published: (2010)

Developing new predictors of Helicobacter pylori associated disease and its progression
by: White, Jonathan Richard
Published: (2017)

Identification and characterisation of toxin-antitoxin systems in Helicobacter pylori tfs ICEs
by: Boampong, Kwadwo
Published: (2019)

Cost-effectiveness of screening and treating Helicobacter pylori for gastric cancer prevention
by: Lansdorp_Vogelaar, Iris, et al.
Published: (2013)

Phylogeographic diversity and mosaicism of the Helicobacter pylori tfs integrative and conjugative elements
by: Delahay, Robin M., et al.
Published: (2018)

Survey in Iran of clarithomycin resistance in Helicobacter pylori isolates by PCR-RFLP
by: Sadeghifard, Nourkhoda, et al.
Published: (2013)

Prevalens Helicobacter Pylori Dalam Pelbagai Kumpulan Etnik Di Pulau Pinang Dan Kaitan Gen H. Pylori Dengan Kepatogenan.
by: Mohamad, Che Wan Sharifah Robiah
Published: (2008)

Reducing the cost of proton pump inhibitors by adopting best practice
by: Hughes, Jeff, et al.
Published: (2009)

Long-Term Proton Pump Inhibitor Therapy and Falls and Fractures in Elderly Women: A Prospective Cohort Study
by: Lewis, J.R., et al.
Published: (2014)

The prevalence of Helicobacter pylori primary resistance towards antibiotics using an Epsilometer-test method
by: Mohamad Zin, Noraziah, et al.
Published: (2018)

Investigating links between the immune response and Helicobacter pylori-mediated disease outcomes
by: Alzahrani, Shatha
Published: (2024)

Association between Helicobacter pylori and pancreatic cancer risk: a meta-analysis
by: Schulte, A., et al.
Published: (2015)

Literature Analysis of Traditional Chinese Medicine Syndrome of Helicobacter Pylori-related Gastropathy
by: Tan, Ying Xze
Published: (2015)

Clinical significance of Helicobacter pylori cagA and iceA genotype status
by: Mohammad Amjad, Nasser, et al.
Published: (2010)

Anti-helicobacter pylori and urease inhibition activities of some traditional medicinal plants.
by: Amin, Muhammad, et al.
Published: (2013)

Identification Of Helicobacter Pylori Antigenic Proteins From Isolates Of Patients With Gastric Pathologies
by: Lee, Chun Wei
Published: (2011)